Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus - Wikidata - awgldk - TriplyDB

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

http://www.wikidata.org/entity/Q24246544

about

Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men Interventions for sexual dysfunction following stroke Interventions for treating sexual dysfunction in patients with chronic kidney disease Apomorphine for the treatment of erectile dysfunction Interventions for treating sexual dysfunction in patients with chronic kidney disease Interventions for sexual dysfunction following treatments for cancer A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials Udenafil for the treatment of erectile dysfunction Udenafil: efficacy and tolerability in the management of erectile dysfunction Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature.Diabetes, obesity and erectile dysfunction: field overview and research priorities.Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials Diabetes and sexual dysfunction: current perspectives.Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives.Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus Erectile dysfunction and its management in patients with diabetes mellitus.Taking the stress out of treating erectile dysfunction.Development and validation of RP-HPLC method for sildenafil citrate in rat plasma-application to pharmacokinetic studies

P2860

Q24194249-78D2B866-8739-490F-8D3A-1EE328056E3F Q24195102-8D34FB3B-31E0-48C0-897D-DFA13F344A5D Q24235471-BE0F8CD8-2458-4064-AE14-476D0AE78CBC Q24236529-46FD6214-6F7F-44EA-8DD8-8A2B60431322 Q24240619-10D712F6-1AB3-41CA-B166-779D46D16E47 Q24242883-EEA540FF-5F9E-4496-B711-B109D7AA656C Q26749094-58E9DE54-DED3-4D6B-8CD3-CB22981E9228 Q26800403-57CD1E88-7962-4EC2-B007-021305BD0067 Q26851999-19651FFA-CB6C-4A04-ADE5-DF12C1AF2BF6 Q28288359-9F50FF3E-0543-486B-BE96-784615EA32E0 Q33632138-7906D932-CF19-42FF-BF22-B2B6CCE8E303 Q33830035-188015BA-FC26-48C4-8FD1-E2A4F8CD5EBD Q33888333-499DB730-676E-46C5-8B40-AD9630F34809 Q37630425-54E74F0E-032B-4911-A903-83117F75F985 Q37686844-EB3F1BD8-346A-4796-A71C-67DBE9914D8A Q37694089-BFB926D4-962B-493D-B74F-4EC5D74AE9F0 Q38466768-3FB14239-C5A7-48DA-951A-8BC3CAA4344B Q38615555-D69A8724-A048-404B-BCC5-2FFBA8315FDF Q42103057-10FDB7A7-1B8D-48B7-B859-99580BC4BF6D Q42557146-20B1C510-6D92-4B49-BF67-5C51F939C02C

P2860

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

http://www.wikidata.org/entity/Q24246544

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@ast

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@en

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@en-gb

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@nl

type

label

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@ast

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@en

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@en-gb

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@nl

prefLabel

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@ast

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@en

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@en-gb

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@nl

P1433

Q24246544-65DD6EC8-929C-43CA-A6DA-EDDFA433AD09

P1476

Q24246544-5C4AF51C-32E3-4293-B323-390A3C77185E

P2093

Q24246544-1712D3B6-61B0-40DB-8864-09D49AE057D1

Q24246544-F25EC857-20F7-4054-B9CA-10A2BD6F413B

P2860

Q24246544-01C489A9-0747-449D-BD0A-8A18EA34C4DD

Q24246544-078D1DF2-0228-4EE7-9FEA-5EBBFC57E44B

Q24246544-1270E47F-8A99-4C48-9AF5-8339560BFADE

Q24246544-203D9D48-E279-49EA-84FB-5AF77F6AD52A

Q24246544-26A55E94-5DC7-496D-8BE1-EFF41170B8B2

Q24246544-34B810B7-EB97-4E23-9E3B-469589B77432

Q24246544-3CF47B25-77B3-4961-B325-0927B2273947

Q24246544-3EB0B225-19A9-46AC-909D-DF1B8B9267ED

Q24246544-4088EED4-5B69-4CA4-905C-2F54D343A5B5

Q24246544-4806C7D4-F721-49D4-B15D-066BCBE046D7

P304

Q24246544-79F13AC7-780F-4B21-BE28-CC7B2493665A

P31

Q24246544-1213FEE3-B71A-4F80-9E3F-84E137660DBF

Q24246544-3b3a03b0-44ef-4b15-acd9-e8cd2455d6ab

P356

Q24246544-F08B9F8E-C17C-4362-944F-20E14AC9A70F

P433

Q24246544-641A40E3-C08E-40DD-9307-07123F078B52

P577

Q24246544-15822153-5F3D-463F-ACC8-5D3807432C0F

P5875

Q24246544-15D63B6E-1065-4FC8-81AF-2F4E61519399

P698

Q24246544-63DD0CB2-69AF-4697-AB50-29C6BAE35858

P921

Q24246544-93A4ACCA-0256-4302-ADB1-C4B25F8B7060

P932

Q24246544-49B2B707-3752-46DC-B637-B6E845C9606D

P356

14651858.CD002187.PUB3

P1433

Cochrane Database of Systematic Reviews

P1476

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

@en

P2093

A Nini

http://www.w3.org/2001/XMLSchema#string

M Vardi

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies.

Pharmacotherapeutic advances in the treatment of erectile dysfunction.

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

P304

CD002187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD002187.PUB3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6551232

http://www.w3.org/2001/XMLSchema#string

P698

17253475

http://www.w3.org/2001/XMLSchema#string

P921

P932

6718223

http://www.w3.org/2001/XMLSchema#string